Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. announced a global supply agreement. Eckert & Ziegler will provide its high-quality non-carrier added Lutetium-177 chloride (n.c.a. Lu-177, Theralugand®) to support AtomVie's CDMO activities for...
read more
Almac are pleased to announce the launch of their novel “Direct to Patient” shipping service for clinical trials recognising the shift in market trends to introduce as many efficiencies as possible into the management of clinical trials and the ...
read more
Tuesday, November 10, 2015
PAREXEL International Corporation, a global biopharmaceutical services provider, has announced expanded evidence-based services for biopharmaceutical products.
read more
Skyhawk Therapeutics has expanded its strategic collaboration with Merck to discover, develop, and commercialize small molecules that modulate RNA splicing.
read more
PharmaBlock, announced the opening of its new R&D facility in West Chester, Pennsylvania. The facility expands the company's footprint in the US and enables more efficient process R&D services and fast delivery of clinical-stage GMP projects to ...
read more
Monday, November 20, 2017
ITUS has entered into a CRADA with Moffitt Cancer Center, to advance toward human clinical testing, a Chimeric Antigen Receptor T-Cell technology.
read more
Wednesday, March 26, 2025
Pharma Tech Industries has received highest-possible marks in its recent Carbon Disclosure Project evaluation. The distinction exemplifies the substantial efforts Pharma Tech Industries has made in the areas of environmental responsibility and ...
read more
Wednesday, February 20, 2019
LabCorp announced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE portfolio.
read more
AstraZeneca and Eli Lilly and Company have entered into a clinical trial collaboration to evaluate the safety and preliminary efficacy of AstraZeneca’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with ramucirumab ...
read more
Wednesday, November 11, 2015
The U.S. Food and Drug Administration has approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can’t be removed by surgery, and that has a certain type of ...
read more
Tuesday, January 09, 2024
Artelo Biosciences, Inc., a clinical-stage pharmaceutical company dedicated to modulating lipid-signaling pathways for developing treatments targeting cancer, pain, and neurological conditions, has chosen Worldwide Clinical Trials, a global contract ...
read more
Wednesday, December 04, 2024
N4 Pharma Plc announced a new lead program N4 101. This orally-delivered inflammation inhibitor for Irritable Bowel Disease (IBD) uses Nuvec®, the company’s novel silica non-viral, non-lipid nanoparticle delivery system, to overcome the challenges ...
read more
Friday, November 13, 2020
Logan Instruments has officially launched their Permeation-Barrier Membrane (PB-M) into international markets.
read more
Wednesday, January 17, 2018
Cambrex held an opening ceremony with AstraZeneca at its Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies for a key intermediate.
read more